Anne E. Calvaresi, DNP, CRNP, RNFA, also discusses best practices that urologists and APPs can follow to ensure they work together well as a team and offers her opinion on the controversy surrounding the use of APPs for performing certain urologic procedures.
The aging urologist population has heightened the importance of advanced-practice providers (APPs) in urology practices, says Anne E. Calvaresi, DNP, CRNP, RNFA, a nurse practitioner at Thomas Jefferson University Hospital in Philadelphia.
Dr. Calvaresi, in this Urology Times video, offers some practical tips for integrating nurse practitioners and physician assistants into your urology practice. She also discusses best practices that urologists and APPs can follow to ensure they work together well as a team and offers her opinion on the controversy surrounding the use of APPs for performing certain urologic procedures.
KIM-1 emerges as biomarker for MRD, atezolizumab benefit in renal cell carcinoma
June 3rd 2024Circulating kidney injury molecule-1 (KIM-1) may be a biomarker for minimal residual disease, disease recurrence, and benefit from adjuvant atezolizumab in patients with renal cell carcinoma at increased risk of recurrence, according to a retrospective analysis of the phase 3 IMmotion010 trial.